About Neurovigil
Neurovigil is a company based in Mountain View (United States) founded in 2007. Neurovigil has raised $250 thousand across 3 funding rounds from investors including DFJ, Zone Ventures and Draper Frontier. Neurovigil offers products and services including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS). Neurovigil operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Ceribell, among others.
- Headquarter Mountain View, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurovigil, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$250 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
DFJ
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurovigil
Neurovigil offers a comprehensive portfolio of products and services, including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).
Portable EEG for real-time brain activity analysis and disease detection
Software for automated EEG data processing and sleep pattern recognition
Technology for interpreting brain signals in research applications
People of Neurovigil
Unlock access to complete
Unlock access to complete
Funding Insights of Neurovigil
Neurovigil has successfully raised a total of $250K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurovigil
Neurovigil has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include DFJ, Zone Ventures and Draper Frontier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused VC firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Seed & early-stage micro VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Neurovigil
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurovigil
Investment portfolio details for Neurovigil
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurovigil
Detailed financials for Neurovigil
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurovigil Comparisons
Peer comparison for Neurovigil
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurovigil
Neurovigil operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Ceribell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
Detailed competitors of Neurovigil
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurovigil
Complete news archive for Neurovigil
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurovigil
Neurovigil was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Neurovigil is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Neurovigil is a funded company, having raised a total of $250K across 3 funding rounds to date.
NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.
Neurovigil's top competitors include Ceribell, Biocare Medical and INBRAIN Neuroelectronics.
Neurovigil offers iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).
Neurovigil has 3 investors. Key investors include DFJ, Zone Ventures, and Draper Frontier.